24СʱÈÈÃŰæ¿éÅÅÐаñ    

²é¿´: 1335  |  »Ø¸´: 4

zrm

ľ³æ (СÓÐÃûÆø)

[½»Á÷] ¡¾ÇóÖú¡¿ÃÀ¹úÒ©µä33°æ ÒÑÓÐ3È˲ÎÓë

ÓÐÃÀ¹úÒ©µä33°æµÄÄÜ·ñ°ïÎÒ²éÏÂË«±ûÎìËáÄÆµÄ±ê×¼£¬Ð»Ð»£¡£¡£¡£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ò»Ö»ºÃÈË

½ð³æ (СÓÐÃûÆø)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ͬÇó£¡Í¬Ç󣡼±Óùþ!Ëͽð±Ò10¸ö
2Â¥2011-08-04 09:57:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ò»Ö»ºÃÈË

½ð³æ (СÓÐÃûÆø)

×Ô¼º¶¥ÆðÀ´ºÇºÇ
3Â¥2011-08-04 09:59:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

kongkong75

½ð³æ (СÓÐÃûÆø)

¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
warlen(½ð±Ò+1): лл²ÎÓë 2011-08-05 10:05:51
Divalproex Sodium
(dye val' proe ex soe' dee um)

(C16H31NaO4)n
310.41
Pentanoic acid, 2-propyl-, sodium salt (2:1);     
Sodium hydrogen bis(2-propylvalerate) oligomer     
DEFINITION
Divalproex Sodium contains NLT 98.0% and NMT 102.0% of available valproic acid (C8H16O2).
IDENTIFICATION
•  A. Infrared Absorption 197K
•  B. Identification Tests¡ªGeneral, Sodium 191: Ignite 100 mg.
ASSAY
•  Procedure
Solution A:  3.5 g of monobasic sodium phosphate monohydrate in 900 mL of water. Adjust with phosphoric acid to a pH of 3.5. Dilute with water to 1 L.
Mobile phase:  Acetonitrile and Solution A (1:1)
Standard stock solution:  5.0 µg/mL of USP Valproic Acid RS in Mobile phase
Standard solution:  0.5 mg/mL of USP Valproic Acid RS, from Standard stock solution in Mobile phase
Impurity stock solution:  0.5 mg/mL of USP Valproic Acid Related Compound A RS in acetonitrile
System suitability solution:  0.5 mg/mL of valproic acid, from Standard stock solution, and 5 µg/mL of valproic acid related compound A, from Impurity stock solution, in Mobile phase
Sample solution:  0.5 mg/mL of Divalproex Sodium in Mobile phase
Chromatographic system  
(See Chromatography 621, System Suitability.)
Mode:  LC
Detector:  UV 215 nm
Column:  4.6-mm ¡Á 15-cm; 5-µm packing L7
Flow rate:  1 mL/min
Injection size:  20 µL
System suitability  
Sample:  System suitability solution
[Note¡ªThe relative retention times for valproic acid related compound A and valproic acid are 0.69 and 1.0, respectively. ]
Suitability requirements  
Resolution:  NLT 5.0 between valproic acid related compound A and valproic acid
Tailing factor:  NMT 1.5 for the valproic acid peak
Relative standard deviation:  NMT 2.0%
Analysis  
Samples:  Standard solution and Sample solution
Calculate the percentage of C8H16O2) in the portion of Divalproex Sodium taken:
Result = (rU/rS) ¡Á (CS/CU) ¡Á (Mr1/Mr2) ¡Á (1/F) ¡Á 100
rU = = peak area from the Sample solution
rS = = peak area from the Standard solution
CS = = concentration of USP Valproic Acid RS in the Standard solution (mg/mL)
CU = = concentration of the Sample solution (mg/mL)
Mr1 = = molecular weight for divalproex sodium repeating unit, 310.41
Mr2 = = molecular weight for valproic acid, 144.21
F = = number of moles of valproic acid/mole of divalproex sodium repeating unit, 2  

Acceptance criteria:  98.0%¨C102.0%
IMPURITIES
Inorganic Impurities  
•  Heavy Metals, Method II 231: NMT 20 ppm
SPECIFIC TESTS
•  Water Determination, Method I 921: NMT 1.0%, determined on 3.0 g
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in tight containers. Store at room temperature
•  USP Reference Standards 11
USP Divalproex Sodium RS  
USP Valproic Acid RS  
USP Valproic Acid Related Compound A RS  
Auxiliary Information¡ª Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ravi Ravichandran, Ph.D.
Senior Scientist
1-301-816-8330 (MDPP05) Monograph Development-Psychiatrics and Psychoactives
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org  

USP33¨CNF28 Page 2830
Pharmacopeial Forum: Volume No. 32(6) Page 1675
Chromatographic Column¡ª  
DIVALPROEX SODIUM
Chromatographic columns text is not derived from, and not part of, USP 33 or NF 28.
ÐÂÒ©Ñз¢¡¢×¢²áÉ걨¡¢Ò©Æ··¨¹æµÈÏà¹Ø×îÐÂÐÅÏ¢×Éѯ£¬ÇëÁªÏµQQ£º609195969
4Â¥2011-08-04 21:41:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÎÄÉÙ520

½ð³æ (ÕýʽдÊÖ)

ͬÇó£¡Í¬Çó£¡
ÎÒÊÇС³æ£¬ÎÒÒªÉý¼¶
5Â¥2012-07-19 10:14:22
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ zrm µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî +12 koalala 2026-08-24 14/700 2026-08-24 12:41 by S09300097
[»ù½ðÉêÇë] 2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË +17 ÑòÑü°å 2026-08-21 18/900 2026-08-24 12:03 by iaeyuan
[»ù½ðÉêÇë] ½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã +12 kulium 2026-08-21 15/750 2026-08-24 12:02 by iaeyuan
[»ù½ðÉêÇë] ÅóÓÑȦ¿´µ½µÄ +7 wangzilk 2026-08-18 9/450 2026-08-24 10:50 by cmrandy
[»ù½ðÉêÇë] ÈÃÎÒÖÐÒ»¸öÃæÉϰɣ¡ +13 ´óƼ1987 2026-08-20 16/800 2026-08-24 10:23 by ̫ɵÁË
[»ù½ðÉêÇë] ¿ÆÑй¶ùÌ«ÄÑÁË +18 ÎÒ4´ó°×²Ë 2026-08-20 19/950 2026-08-24 09:47 by ¿­¶÷¹ãÊ¢´ß»¯·ÖÎ
[»ù½ðÉêÇë] ʲôʱºò¿ª½±£¿ +10 CrisMessi 2026-08-18 11/550 2026-08-24 06:50 by ¿ªÐĵÄСʨ×Ó
[½Ìʦ֮¼Ò] Ìø²ÛºóÔÚÑÐÏîÄ¿Ôõô°ì£¿ +5 ¼òµ¥»¯xn 2026-08-22 10/500 2026-08-23 12:38 by ¼òµ¥»¯xn
[»ù½ðÉêÇë] ½ñÌì·Å°ñÂ𣿠+15 ²¼²¼ºÍÒ»¶þ 2026-08-19 16/800 2026-08-23 09:55 by ÕÅ´ºÉú
[»ù½ðÉêÇë] 93BebMhtakhǰºó11λ¿ªÍ·¶¼ÊÇ´óд +7 ÇÒÌý»¢Ð¥ 2026-08-17 8/400 2026-08-22 21:55 by ҽѧÀÏÄк¢
[»ù½ðÉêÇë] Ö»ÓÐÿÄêÕâÖÖʱºòÀ´¹ä¹äСľ³æ +24 yaoyewhu2008 2026-08-20 26/1300 2026-08-22 17:43 by kammury
[»ù½ðÉêÇë] ½ñÌì»ù½ð»á³ö½á¹ûÂð£¿20260819 +16 kkkl_v 2026-08-19 17/850 2026-08-22 16:12 by °¢²¼Abu
[»ù½ðÉêÇë] ¿´À´½ñÌì²»»á·Å°ñÁË£¿ +8 chengyan1220 2026-08-21 11/550 2026-08-21 17:52 by dcqxinyang
[»ù½ðÉêÇë] ʱ¼ä´ÁÓÖ±äÁË +13 wuchongjun 2026-08-20 19/950 2026-08-21 17:21 by ×Ïɼ´¼
[»ù½ðÉêÇë] Ó¦¸ÃÊÇÏÂÖÜÈý26ÈÕ¹«²¼Á˰ɣ¿ +4 ¹þ¹þ¸ò£¿ 2026-08-21 4/200 2026-08-21 10:58 by Vivilian
[ÂÛÎÄͶ¸å] Ͷ¸å×Éѯ +5 wwm09 2026-08-17 7/350 2026-08-21 10:11 by ÆÚ¿¯ÂÛÎİïÊÖ
[»ù½ðÉêÇë] ½ñÌì·Å°ñûϷÁ衃 +9 yuleib84 2026-08-19 11/550 2026-08-21 10:06 by gltch
[»ù½ðÉêÇë] »ù½ð°¡»ù½ð +4 longfie172 2026-08-20 4/200 2026-08-21 08:58 by mark mao
[»ù½ðÉêÇë] ¹À¼ÆÊÇÖÜËÄ +3 archvillain 2026-08-18 3/150 2026-08-21 01:48 by jnhyjjm
[»ù½ðÉêÇë] ½ñÌìά»¤ÏµÍ³Î¬»¤ ×£ËùÓÐÈË ¸ßÖÐ +8 gjjjzhong 2026-08-18 9/450 2026-08-18 13:01 by ¼ÒÓëÔ¶·½
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û